Literature DB >> 7546656

Listeria monocytogenes: a live vector able to deliver heterologous protein within the cytosol and to drive a CD8 dependent T cell response.

P L Goossens1, C Montixi, M F Saron, M Rodriguez, F Zavala, G Milon.   

Abstract

After an introduction on the entry and lifestyle of Listeria monocytogenes within mammalian eucaryotic cells, this chapter gives a brief overview of murine experimental listeriosis. Among the main characteristics of this murine model of infectious/pathogenic processes initiated by a facultative intracellular bacteria, we point out two main recent advances. One relates to Listeria monocytogenes-induced production of cytokines as local, and transient signals able to direct the immune responses along a type 1 pathway of CD4/CD8 T cell differentiation. The other relates (a) to the recognition of L. monocytogenes-reactive CD8+ T lymphocytes as effectors able, once recruited within infected loci, to critically contribute to the complete clearance of the bacteria, and (b) to the recently recognized specificity of some of these CD8 lymphocytes in BALB/c mice. In this paper, we also briefly review (a) the readout assays presently used to monitor the outcome of the infectious/pathogenic processes and the related development and expression of immune responses induced by intravenous inoculation of wild-type virulent or attenuated L. Monocytogenes, (b) why all this information allows us to consider the use of L monocytogenes of attenuated virulence as relevant live recombinant vectors in order to deliver heterologous proteins to the class I processing and presentation pathway, and to induce CD8 T cells along the type 1 pathway.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7546656     DOI: 10.1006/biol.1995.0024

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  5 in total

1.  Listeria monocytogenes as a short-lived delivery system for the induction of type 1 cell-mediated immunity against the p36/LACK antigen of Leishmania major.

Authors:  N Soussi; G Milon; J H Colle; E Mougneau; N Glaichenhaus; P L Goossens
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

2.  Enteral immunization with attenuated recombinant Listeria monocytogenes as a live vaccine vector: organ-dependent dynamics of CD4 T lymphocytes reactive to a Leishmania major tracer epitope.

Authors:  Hélène Saklani-Jusforgues; Elisabeth Fontan; Neirouz Soussi; Geneviève Milon; Pierre L Goossens
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

3.  Oral immunization with recombinant listeria monocytogenes controls virus load after vaginal challenge with feline immunodeficiency virus.

Authors:  Rosemary Stevens; Kristina E Howard; Sushila Nordone; MaryJo Burkhard; Gregg A Dean
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

4.  Alteration of pulmonary immunity to Listeria monocytogenes by diesel exhaust particles (DEPs). II. Effects of DEPs on T-cell-mediated immune responses in rats.

Authors:  Xue-Jun Yin; Rosana Schafer; Jane Y C Ma; James M Antonini; Jenny R Roberts; David N Weissman; Paul D Siegel; Joseph K H Ma
Journal:  Environ Health Perspect       Date:  2003-04       Impact factor: 9.031

Review 5.  Therapeutic vaccines for high-risk HPV-associated diseases.

Authors:  Aleyo Chabeda; Romana J R Yanez; Renate Lamprecht; Ann E Meyers; Edward P Rybicki; Inga I Hitzeroth
Journal:  Papillomavirus Res       Date:  2017-12-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.